Generation of cerebral corticalGABAergicinterneurons from pluripotent stem cells
Generation of cerebral corticalGABAergicinterneurons from pluripotent stem cells
复制标题
DOI:
10.1002/stem.3252
复制
发表时间:
2020-09-02
期刊:
影响因子:
5.2
通讯作者:
Anderson,Stewart A.
中科院分区:
文献类型:
--
作者:
Fitzgerald,Megan;Sotuyo,Nathaniel;Anderson,Stewart A.
The cerebral cortex functions by the complex interactions of intrinsic and extrinsic neuronal activities, glial actions, and the effects of humoral factors. The intrinsic neuronal influences are mediated by two major subclasses: excitatory glutamatergic neurons that generally have axonal projections extending beyond the neuron's locality and inhibitory GABAergic neurons that generally project locally. These interneurons can be grouped based on morphological, neurochemical, electrophysiological, axonal targeting, and circuit influence characteristics. Cortical interneurons (CIns) can also be grouped based on their origins within the subcortical telencephalon. Interneuron subtypes, of which a dozen or more are thought to exist, are characterized by combinations of these subgrouping features. Due to their well-documented relevance to the causes of and treatments for neuropsychiatric disorders, and to their remarkable capacity to migrate extensively following transplantation, there has been tremendous interest in generating cortical GABAergic interneurons from human pluripotent stem cells. In this concise review, we discuss recent progress in understanding how interneuron subtypes are generated in vivo, and how that progress is being applied to the generation of rodent and human CIns in vitro. In addition, we will discuss approaches for the rigorous designation of interneuron subgroups or subtypes in transplantation studies, and challenges to this field, including the protracted maturation of human interneurons.Significance statementThe identification of multiple forebrain “interneuronopathies” featuring neuropsychiatric symptoms, as well as the efficacy of transplants of embryo-derived interneurons in rodent models of disorders featuring forebrain disinhibition, has engendered tremendous interest in deriving cerebral cortical GABAergic interneurons from pluripotent stem cells. This review considers progress in this derivation and the remaining challenges to the use of stem cell-derived cortical interneurons in the study and treatment of forebrain disease.